Singapore: Dengue, also known as break bone fever, is currently the most common vector-borne disease. The World Health ...
Singapore: Novartis received US FDA breakthrough therapy designation for BYM338 (bimagrumab) for sporadic inclusion body...
Singapore: Singapore based start-up firm, NMT Pharmaceuticals, has acquired an exclusive worldwide license right to furt...
Singapore: Boehringer Ingelheim and Circuit Therapeutics have formed a three-year collaboration to focus on investigatin...
Takeda Pharmaceutical Company Ltd and Paris-headquartered Enterome Bioscience SA have entered into a strategic drug disc...
Japan's Eisai Co Ltd has announced that its US subsidiary Eisai Inc. has received approval from the US Food and Drug Adm...
Singapore: SCIEX, a global leader in life science analytical technologies, and the Protein and Proteomics Centre (PPC) u...
The Japanese Pharmaceutical Affairs and Food Sanitation Council (PAFSC) has recommended an approval for Madrid-based Pha...
Singapore: European Medicines Agency (EMA) has recommended granting a marketing authorisation for Bristol-Myers Squibb's...
Singapore: Australia based Paradigm Biopharmaceuticals has been granted a patent by United States Patent and Trademark O...
Singapore: World Health Organization has launched "Roadmap for childhood TB: towards zero deaths", in an effort to preve...
Singapore: China's leading pharmaceutical firm Yabao Pharmaceutical has inked a pact with the University of South Austra...
Singapore: Celgene International has received European Commission (EC) approval for VIDAZA (azacitidine for injection) f...
InvitroCue, the Australian company that works on advanced bio-analytics, has announced a key initiative on Malaria to id...
Singapore: Bionomics, Australia based biopharmaceutical company focused on the discovery and development of innovative t...
Singapore: The oncology drug pipeline is far larger than any other therapy area across the pharmaceutical industry, with...
Researchers affiliated with Kawasaki Innovation Gateway at SKYFRONT, Japan have discovered that incorporating gold nanop...
Singapore: Japan's Astellas Pharma and Potenza Therapeutics, a biotechnology company developing a portfolio of immuno-on...
